Arizona State Retirement System Purchases 580 Shares of Solventum Co. (NYSE:SOLV)

Arizona State Retirement System raised its holdings in shares of Solventum Co. (NYSE:SOLV) by 1.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,639 shares of the company’s stock after acquiring an additional 580 shares during the quarter. Arizona State Retirement System’s holdings in Solventum were worth $2,817,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Modus Advisors LLC purchased a new stake in shares of Solventum during the fourth quarter worth about $25,000. Stonebridge Financial Group LLC purchased a new stake in Solventum during the 4th quarter valued at approximately $26,000. Crews Bank & Trust bought a new stake in shares of Solventum during the fourth quarter valued at approximately $32,000. True Wealth Design LLC lifted its holdings in shares of Solventum by 23,550.0% in the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after buying an additional 471 shares in the last quarter. Finally, Prospera Private Wealth LLC bought a new position in shares of Solventum during the third quarter worth $35,000.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Morgan Stanley lifted their price target on shares of Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a report on Wednesday, March 5th. Piper Sandler lifted their target price on Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a report on Friday, February 28th. Wells Fargo & Company increased their price target on Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Mizuho lifted their price objective on Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a research note on Monday, March 3rd. Finally, Bank of America upped their price objective on Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $79.86.

Solventum Price Performance

NYSE:SOLV opened at $77.96 on Monday. The firm has a market capitalization of $13.49 billion and a price-to-earnings ratio of 28.35. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The business has a 50 day simple moving average of $73.65 and a 200-day simple moving average of $70.71. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $85.92.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.